Johnson & Johnson EV/Sales
Was ist das EV/Sales von Johnson & Johnson?
EV/Sales von Johnson & Johnson ist 5.93
Was ist die Definition von EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales von Unternehmen in Health Care Sektor auf NYSE im Vergleich zu Johnson & Johnson
Was macht Johnson & Johnson?
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Unternehmen mit ev/sales ähnlich Johnson & Johnson
- Paramount Inc hat EV/Sales von 5.92
- Mcphy S.A. Eo 0,12 hat EV/Sales von 5.92
- Crossword Cybersecurity Plc hat EV/Sales von 5.92
- iShares € Corp Bond 0-3yr ESG UCITS ETF EUR (Dist) hat EV/Sales von 5.93
- Budweiser Brewing APAC hat EV/Sales von 5.93
- Vixtel Technologies hat EV/Sales von 5.93
- Johnson & Johnson hat EV/Sales von 5.93
- ASM International NV hat EV/Sales von 5.94
- SiteMinder hat EV/Sales von 5.94
- Aon plc hat EV/Sales von 5.94
- Atlas hat EV/Sales von 5.94
- Housing Development Finance hat EV/Sales von 5.94
- Avid Bioservices Inc hat EV/Sales von 5.94